Trials / Completed
CompletedNCT01008943
Autologous Cell Therapy for Female Stress Urinary Incontinence
A Canadian Prospective Nonrandomized Study of Autologous Cell Therapy for Female Stress Urinary Incontinence
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Cook MyoSite · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Autologous Cell Therapy for Female SUI study is a clinical trial to determine the safety and potential effectiveness of a single dose of 200 million Cook MyoSite Autologous Muscle Derived Cells for treatment of Stress Urinary Incontinence.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Muscle Derived Cells | Urethral injection of autologous muscle-derived cells |
Timeline
- Start date
- 2010-06-02
- Primary completion
- 2012-09-21
- Completion
- 2012-09-21
- First posted
- 2009-11-06
- Last updated
- 2021-07-01
- Results posted
- 2015-11-03
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT01008943. Inclusion in this directory is not an endorsement.